Inflamyar
Inflamyar is an FDA drug label for the active ingredient ARNICA MONTANA, BELLIS PERENNIS, BRYONIA CRETICA SUBSP. DIOICA ROOT, GUAIACUM OFFICINALE RESIN, LEDUM PALUSTRE TWIG, RUTA GRAVEOLENS WHOLE, TOXICODENDRON PUBESCENS LEAF, AND VISCUM ALBUM FRUIT manufactured by Pekana-Naturheilmittel GmbH administered by ORAL. This page reproduces the FDA-approved indications and usage, dosage, contraindications, warnings, and adverse reactions exactly as published in the drug label. Data source: openFDA (U.S. FDA), label effective 20221215.
- Generic name
- ARNICA MONTANA, BELLIS PERENNIS, BRYONIA CRETICA SUBSP. DIOICA ROOT, GUAIACUM OFFICINALE RESIN, LEDUM PALUSTRE TWIG, RUTA GRAVEOLENS WHOLE, TOXICODENDRON PUBESCENS LEAF, AND VISCUM ALBUM FRUIT
- Manufacturer
- Pekana-Naturheilmittel GmbH
- Product type
- HUMAN OTC DRUG
- Route
- ORAL
- Dosage form
- N/A
- NDC
- 59469-172
- Application
- N/A
- Label effective
- 20221215
Active ingredients
Indications & Usage
Indications For relief of minor sports injuries, including muscle strains, joint pain, sprains, and bruises. Application of this homeopathic remedy for the designated usage is exclusively based on homeopathic experience. With severe forms of this disease, a clinically proven therapy is indicated.
Dosage & Administration
Dosage Unless otherwise prescribed, adults take 10 pellets, 4 times per day. For pediatric dosages, consult your practitioner.
Contraindications
Not available.
Warnings
Warning If symptoms persist, contact a licensed practitioner. If you have known sensitivity to any of the ingredients, please consult your licensed practitioner before use. If you are pregnant or nursing a baby, seek the advice of a health care professional before use. Keep out of the reach of children. Protect from light and heat. Tamper Evident Do not use this product if tamper evident strip is broken or removed from base of cap.
Adverse Reactions
Not available.